Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 514.00
+6.00 (1.18%)
Aug 4, 2026, 3:03 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 5.06 billion as of August 3, 2026. Its market cap has decreased by -9.44% in one year.
Market Cap
5.06B
Enterprise Value
2.76B
Revenue
234.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
514.00
ChartMarket Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 5.06B, a decrease of -61.07%. That is a compound annual growth rate of -22.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 5.06B | -10.74% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Koa Shoji Holdings | 32.73B |
| Mizuho Medy | 31.94B |
| Fuso Pharmaceutical Industries,Ltd. | 18.57B |
| Pharma Foods International | 16.21B |
| Taiko Pharmaceutical | 12.71B |
| Wakamoto Pharmaceutical | 9.39B |
| Morishita Jintan | 9.06B |
| Solasia Pharma K.K. | 7.64B |